FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095178 [Registered on: 22/09/2025] Trial Registered Prospectively
Last Modified On: 20/09/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Yoga & Naturopathy
Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect OF YOGA INTEGRATED HEALTH EMPOWERMENT PROGRAM ON Health Awareness, Selected physiological Variables and Quality of Life among women with Sickle cell anemia 
Scientific Title of Study   Impact of yoga integrated health empowerment program on health literacy, biophysical, biochemical variables and quality of life among women with sickle cell anemia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  ASHWINI KN 
Designation  TUTOR 
Affiliation  AIIMS NAGPUR 
Address  College of Nursing,4th Floor, Paramedical Academy, AIIMS CAMPUS,MIHAN

Nagpur
MAHARASHTRA
441108
India 
Phone  9677139002  
Fax    
Email  ashwinibalaji84@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  ASHWINI KN 
Designation  TUTOR 
Affiliation  AIIMS NAGPUR 
Address  College of Nursing,4th Floor, Paramedical Academy, AIIMS CAMPUS,MIHAN

Nagpur
MAHARASHTRA
441108
India 
Phone  9677139002  
Fax    
Email  ashwinibalaji84@gmail.com  
 
Details of Contact Person
Public Query
 
Name  ASHWINI KN 
Designation  TUTOR 
Affiliation  AIIMS NAGPUR 
Address  College of Nursing,4th Floor, Paramedical Academy, AIIMS CAMPUS,MIHAN

Nagpur
MAHARASHTRA
441108
India 
Phone  9677139002  
Fax    
Email  ashwinibalaji84@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  ASHWINI KN 
Address  TUTOR,COLLEGE OF NURSING,AIIMS NAGPUR 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr ASHWINI KN  AIIMS NAGPUR  Plot No 2 ,Sector 2o, MIHAN CAMPUS, NAGPUR
Nagpur
MAHARASHTRA 
9677139002

ashwinibalaji84@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC,AIIMS NAGPUR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D571||Sickle-cell disease without crisis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Standard treatment for sickle cell disease including Hydroxyurea  Standard treatment of Sickle cell anemia includes Hydroxyurea and medical management of symptoms such as analgesics, antibiotics 
Intervention  Yoga Integrated Health Empowerment Program  1. Yoga -pranayama and asanas is conducted as a 40 – 45 minutes session on WEEK 1. Thereafter yoga sessions will be conducted weekly twice by PI and certified yoga instructor at AIIMS Nagpur. Each session consists of Warm up or relaxation loosening exercises (Sukshama Vyama)- 5 minutes Pranayama (Kapalabhati and Nadisuddhi)- 20 minutes Predefined set of asanas (20 minutes) 2. Health empowerment program – one to one health teaching given by PI on SCD using print (pamphlets) and audiovisual media to study group participants during every visit to the hospital. The program will include causes, symptoms, screening, prevention, medical management, diet modification, stress management)  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Women who are Clinically proven sickle cell anemic via HPLC,18 - 45 years of age, who are in a steady state (absence of complications and acute VOC atleast for the past one month), have complaints of chronic pain (pain more than 6 months duration with pain score in the range of 4 - 7), Access to smart phone or digital gadgets, willingness for participation followed by clinical consent, Women with noncommunicable diseases in a controlled state and receiving treatment according to standard guidelines will be included in the study.  
 
ExclusionCriteria 
Details  women who are critically ill, known pregnancy and lactation, cognitive or physical impairment, those who are practicing yoga already regularly. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Primary -
Mean change in expression of inflammatory biomarker (C reactive protein and TNF alpha), (decreased chronic pain score, stable blood pressure, stable heart rate, stable respiratory rate, stable oxygen saturation, decreased pain during menstruation), health literacy scores , Quality-of-life scores as determined by standardized tool in women with sickle cell anemia from baseline to 3 months in study arm
 
At baseline and end of 12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary-
Mean change in frequency of VOC, prescription need for analgesic use, hospital admissions
 
12 weeks 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Background and Rationale

Sickle cell anemia is a prevalent hemolytic disorder in Indian populations, particularly in Central India. Women with sickle cell disease (SCD) suffer both disease-related complications and unique challenges regarding reproductive health, chronic pain, and social functioning. Standard management includes hydroxyurea, pain control, and community interventions, yet frequent vaso-occlusive crises and chronic pain impair life quality. Complementary approaches such as yoga have shown promise for pain reduction, inflammation control, and holistic health support—especially important for women, who may face gaps in conventional care and awareness. This study addresses the need for integrated, evidence-based strategies to enhance self-care, literacy, and psychosocial outcomes among women with SCD. The Objectives of the study are to assess whether a yoga-integrated health empowerment program significantly improves health literacy, biophysical and biochemical markers (including chronic pain scores and inflammation), and quality-of-life indicators, To explore the relationships among health literacy, physical markers, biochemical markers, and quality of life in women with SCD. Methodology: This is a randomized controlled trial (RCT) with two parallel arms: (1) standard medical treatment including hydroxyurea, and (2) standard treatment plus a structured yoga-based health empowerment program. Women aged 18–45 years with clinically proven SCD and stable conditions, who experience chronic pain and possess digital access, will be recruited through the Sickle Cell OPD at AIIMS Nagpur. The yoga module consists of supervised in-person and virtual sessions (pranayama, asana, relaxation) twice weekly, supplemented by ongoing health education (printed and digital materials) on disease management, self-care, and coping strategies. Baseline and post-intervention assessments (at week 13) include validated questionnaires for health literacy, pain score (VAS), quality of life (ASCQ-Me), biophysical measurements, and laboratory testing for inflammatory markers (CRP, TNF-alpha). The total planned sample size is 100 women (50 per group), with tools and procedures detailed for randomization, allocation concealment (SNOSE method), and blinding of assessors where feasible. Careful strategies support intervention adherence, including daily virtual contact, WhatsApp groups, appointment reminders, and family engagement. Adverse events are monitored, with clear criteria for intervention discontinuation and ongoing follow-up for all participants, including post-study care offered to controls. The primary outcomes of the study are mean changes in health literacy, biophysical and biochemical markers, and quality of life over three months. Secondary outcomes include reductions in vaso-occlusive crisis frequency, analgesic requirements, and hospital admissions. Data will be analyzed using intention-to-treat principles, with t-tests, ANCOVA, correlation, and regression analyses applied. All procedures meet ethical standards with informed consent, confidentiality, and IEC oversight. This study innovatively combines yoga therapy with health literacy and empowerment training for women with SCD—a population experiencing high burdens yet low awareness and support. Its rigorous design, validated tools, and strong outcome focus position it to yield actionable insights for integrative, gender-sensitive chronic disease care and policy in India.

 
Close